Treatment of infections

Details for Australian Patent Application No. 2010272505 (hide)

Owner GlaxoSmithKline Biologicals s.a. The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin

Inventors Tarkowski, Andrej; Foster, Timothy; Higgins, Judy; Josefsson, Elisabet; Geoghegan, Joan; Dequesne, Guy

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010272505

PCT Pub. Number WO2011/007004

Priority 2009/0549 16.07.09 IE

Filing date 16 July 2010

Wipo publication date 20 January 2011

International Classifications

C07K 14/31 (2006.01) Peptides having more than 20 amino acids

A61K 39/085 (2006.01) Medicinal preparations containing antigens or antibodies - Staphylococcus

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2011/007004 Priority application(s): WO2011/007004

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010272514-ZNF217 a new prognostic and predictive biomarker of recurrent, invasive and metastatic phenotypes in breast cancer

2010272503-Surgical guiding tool, methods for manufacture and uses thereof